Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCarol Davila University of Medicine and Pharmacy

About this trial

The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patient with ascites and chronic liver failure

no contraindications and technical possibility to perform diagnostic paracentesis

age above 18 years old

informed consent

Disqualifiers

contraindications to paracentesis or technical impossibility to perform paracentesis

absence of informed consent

Trial population

Adult patients admitted with chronic liver failure and ascites. A diagnostic paracentesis will be performed at the day of admission.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Determination of presepsin levels in ascites

    Diagnostic test

    A diagnostic paracentesis will be performed and presepsin level will be determined in ascites.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Patients with chronic liver failure and ascites1 intervention

Trial outcomes

Primary outcomes

1

Mortality at 6 months

Number of who deceased during admission or during the 180 days after admission divided by the number of patients who were admitted. An analysis will be done to see if the presepsin levels are predictive for this event.

Time frame
6 months

Secondary outcomes

1

Spontaneous bacterial peritonitis (SBP) rate

The number of patients diagnosed with SBP during admission divided by the total number of patients. An analysis will be done to see if the presepsin levels are predictive for this event.

Time frame
6 months
2

Hepatic encephalopathy rate

Number of patients diagnosed with hepatic encephalopathy during admission divided by the total number of patients. An analysis will be done to see if the presepsin levels are predictive for this event.

Time frame
6 months
3

Any infection rate

The number of patients diagnosed with any infection during admission divided by the total number of patients. An analysis will be done to see if the presepsin levels are predictive for this event.

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.